BlackRock Investment Management’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $4.22M | Sell |
253,090
-588
| -0.2% | -$9.8K | ﹤0.01% | 1705 |
|
|
2016
Q3 | $5.22M | Sell |
253,678
-428
| -0.2% | -$8.81K | 0.01% | 1452 |
|
|
2016
Q2 | $7.78M | Buy |
254,106
+14,591
| +6% | +$447K | 0.01% | 1113 |
|
|
2016
Q1 | $8.97M | Buy |
239,515
+7,081
| +3% | +$265K | 0.01% | 991 |
|
|
2015
Q4 | $10M | Buy |
232,434
+1,354
| +0.6% | +$58.4K | 0.01% | 939 |
|
|
2015
Q3 | $8.66M | Sell |
231,080
-2,890
| -1% | -$108K | 0.01% | 1011 |
|
|
2015
Q2 | $7.95M | Buy |
233,970
+208,854
| +832% | +$7.1M | 0.01% | 1156 |
|
|
2015
Q1 | $889K | Sell |
25,116
-1,253
| -5% | -$44.4K | ﹤0.01% | 2598 |
|
|
2014
Q4 | $898K | Sell |
26,369
-637
| -2% | -$21.7K | ﹤0.01% | 2611 |
|
|
2014
Q3 | $1.04M | Sell |
27,006
-24,703
| -48% | -$953K | ﹤0.01% | 2486 |
|
|
2014
Q2 | $2.01M | Sell |
51,709
-151,440
| -75% | -$5.9M | ﹤0.01% | 2061 |
|
|
2014
Q1 | $6.95M | Buy |
203,149
+8,574
| +4% | +$293K | 0.01% | 1144 |
|
|
2013
Q4 | $4.08M | Buy |
194,575
+133,834
| +220% | +$2.81M | 0.01% | 1488 |
|
|
2013
Q3 | $1.43M | Buy |
60,741
+7,607
| +14% | +$179K | ﹤0.01% | 2176 |
|
|
2013
Q2 | $1.43M | Buy |
+53,134
| New | +$1.43M | ﹤0.01% | 2109 |
|